![Doron Sagman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Doron Sagman served as the Senior Medical Director and VP-Research & Development at Eli Lilly Canada, Inc. He also worked as the Chief Medical Officer at Mind Cure Health, Inc. in 2021-2022.
Sagman holds a doctorate degree from the University of Calgary.
Former positions of Doron Sagman
Companies | Position | End |
---|---|---|
LNG ENERGY GROUP CORP. | Chief Tech/Sci/R&D Officer | 2022-02-28 |
Eli Lilly Canada, Inc.
![]() Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Canada, Inc. is a healthcare leader that focuses on oncology, diabetes, autoimmunity, neurodegeneration, and pain. The company is based in Scarborough, Canada. Established in 1938, the Canadian company collaborates with scientists to produce innovative medicines that make life better for people around the world. The company's mission is to discover and bring life-changing medicines to people who need them, improve the understanding and management of disease, and contribute to communities through philanthropy and volunteerism. | Chief Tech/Sci/R&D Officer | - |
Training of Doron Sagman
University of Calgary | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Mind Cure Health, Inc.
![]() Mind Cure Health, Inc. Pharmaceuticals: OtherHealth Technology Mind Cure Health, Inc. operates as a life sciences company to identify and develop products that enhance mental health and wellness. The firm focuses on developing digital therapeutics technology and researching psychedelic compounds to rapidly scale science-backed and evidence-based mental health therapy globally. Its software iSTYRM is designed to provide close to real-time data regarding patient care, procedures and protocols, and other resources for therapists, practitioners and patients with mental health concerns. The company was founded by Philip Tapley on March 6, 2020 and is headquartered in Vancouver, Canada. | Health Technology |
Eli Lilly Canada, Inc.
![]() Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Canada, Inc. is a healthcare leader that focuses on oncology, diabetes, autoimmunity, neurodegeneration, and pain. The company is based in Scarborough, Canada. Established in 1938, the Canadian company collaborates with scientists to produce innovative medicines that make life better for people around the world. The company's mission is to discover and bring life-changing medicines to people who need them, improve the understanding and management of disease, and contribute to communities through philanthropy and volunteerism. | Health Technology |
- Stock Market
- Insiders
- Doron Sagman